underlying holdings of the fund. November 03, 2023 — 10:50 am EDT. 10 as of November 2, 2022. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. NAV as of Nov 09, 2023. Below is the comparison between VHT and XBI. 12% in the last one year (as. 94 per share, with $107. As of 09/30/2023. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. ETFs Holding XBI. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. Seagen Inc Ordinary Shares. Historical Price Data. 78% of XBI's total assets under management. Top Holdings . 80% of total assets under management. XBI is suitable for investors seeking to. $36. argenx SE ADR. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Search tickers or categories. $6. MTD. 77% for the trailing three-year period, which makes the fund a high risk choice in the space. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. ETF Summary. 96%, and is down about -5. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 22%: Revolution. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. Dividend ETFs. 96%, and is down about -5. 1. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. 0 reviews. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. Below is the comparison between IBB and XBI. XBI Holdings 5 Beaten-Down ETFs to Buy Now. Wix. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. Analysis of these related ETFs and how they are trading may provide insight to this commodity. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. Performance and Risk. XBI is a modified equal weighted ETF with about 157 holdings, though that number may change due to issues such as being acquired, among others. The XBI has been a leader beating other ETFs YTD, up about 35% until today. LABD. SPDR® S&P Biotech ETF XBI: NYSE Arca . 79 in February 2021 and has fallen over (50%) to $76. Minafi categorizes both of these funds as large funds. Shares Held Weight In Fund. Based on its analysis of these factors, SSGA Funds Management, Inc. 7,569,600. Assets Under Management. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. Single Cell Genomics Workflow Automation Cell Analytics Lab Equipment Spatial Genomics Lab Equipment. 16bn USD. 40. 26% rating in the component of Value. XBI: SPDR S&P Biotech ETF - Fund Holdings. SPDR S&P Biotech ETF Stock Up 1. 1005 Broad St 5 Victoria BC V8W 2A1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 03 per $1,000 of principal). 40. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. S. 01 to $0. 38%. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). •. A few losers won't cause XBI to crash. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. 7. The ETF has lost about -22. Twin City Holdings Ltd. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. As a result, the ETF reached a new 8-month low. 11. The top XBI holdings:Glossary: ActiveShareis a measure of the percentage of stock holdings in a manager's portfolio that differ from the benchmark index. 26%. Both VHT and XBI are ETFs. 35%). 19%. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. " The 12-month stock price forecast is $22. Below is the comparison between BBC and XBI. Asset type. In addition to holding 155 positions, its top 10 holdings make up just 14. With about 151 holdings, it effectively. total market composite index. 84 Billion in assets under management, while XBI has 4. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. 66 +2. The Direxion Daily Cloud Computing Bull 2X Shares seek daily investment results, before fees and expenses, of 200% of the performance of the Indxx USA Cloud Computing Index. 20 -4. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. Start Free Trial. Mettler-Toledo International Inc. Themes & Subsectors ETFs. XBI has lost 27. $7. The Composition of the XBI is the Key. 01% vs 0. Feel free to the browse the list and view the comparisons that are of an interest to you. 07. XBI - SPDR (R) S&P (R) Biotech ETFs top. Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. No, even the large cap biotechs get pumped before a final FDA decision on a drug in their pipeline and usually have a sell off after on profit taking or a failed decision. VHT has a higher 5-year return than XBI (7. All 142 XBI Holdings. Real Estate ETFs. IBB has 8. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. ARKG vs XBI Fund Comparison . Comparing XBI with other biotech ETFs, we note that XBI is one of the largest with around US$8 billion in assets under management and has one of the lowest expense ratios at 0. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. Growth of Hypothetical $10,000. 79 as the 52 week high point — that compares with a last trade of $133. XBI’s Holdings. 10(-0. 67% Symbol Company Name Industry Percent of Assets MRTX Mirati Therapeutics Inc Biotechnology 2. XBI touched $73. Looking at the chart above, XBI's low point in its 52 week range is $62. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. The gross expense ratio is the fund’s total annual operating expenses ratio. 3. Implied XBI Analyst Target Price: $135. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. ETF Strategies. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. 44 per share, with $92. Trades. Its price to cash flow multiples is about 13. Figure 1 - XBI ETF top 10 holdings (ssga. $72. 8 million shares. IMVT. View the latest SPDR S&P Biotech ETF (XBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. 60 as the 52 week high point — that compares with a last trade of $77. Components of. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. AU. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. 00%) Most Recent Dividend 0. Summary. Comparing the most. Mirati Therapeutics. XBI has a Diversified Portfolio. 35% vs 0. News & World Report, XBI enjoys volume of 20. 97. Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006. ValueStrategy: Traditional value investing is an investment strategy where stocks are selected that trade for less than their intrinsic values. Currency in USD Follow 2W 10W 9M 72. 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. XBI, whose index recently expanded, also owns only a handful of established biotech companies. 35%. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. Its top 10 holdings account for approximately 16. 99%. With about 135 holdings, it effectively. A few losers won't cause XBI to crash. The company has an 88. **Close price adjusted for splits and dividend and/or capital gain distributions. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. ETF Channel Staff - Friday, October 20, 6:48 AM. SPDR S&P Biotech ETF ETF holdings by MarketWatch. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. Additionally. Below is the comparison between BBH and XBI. 1% vs 0. 1% and 1. 08 per unit, that means that analysts see 59. 5% year-to-date and 38. ARGX. Monday's ETF Movers: XBI, QCLN. The beaten-down prices offer a solid buying opportunity for investors. View complete XBI exchange traded fund holdings for better informed ETF trading. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Complete SPDR S&P Biotech ETF funds overview by Barron's. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 1% and 1. Seeking AlphaXBI vs. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. BlackRock Files for Spot Ethereum ETF. 3% over the same period: Image Source: Zacks Investment Research. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. Site search Search. $5. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. XBI holdings. GrowthStrategy: Traditional growth investing is an investment. XBI: Head-To-Head ETF Comparison. One of the ideas making the rounds on Wall Street right now (I’ve seen it commented on in a number of places) is buying XBI, the SPDR S&P Biotech ETF, at this time of year, for a spring rally. S. 51. Like IBB, XBI uses diversification to. 46M), Matrix Capital Management Company LP ($188. Total healthcare and life sciences M&A was about $71. 17% for the trailing three-year period, which makes XBI a high. 35%). Trade XBI with: Price/Earnings ttm 17. Please call us for more information - (250). Visitors trend 2W 10W 9M. S. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. 10% of. 0. 84. 🇺🇸. XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. 9%: Israel: 3. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. In that past 52-week period, it has traded between $62. LABD. 18% and is down about -39. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. ($423. Performance and Risk. The firm has a market cap of $5. There are a number of factors behind this strategy, the overriding one being that biotech has pulled back in the fall a large percentage of the. Holdings; Holdings Overlap; Attribution; Fundamental Chart; Scatter Plot; Tech Chart; Stress Test; ESG; Data; More. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. ETF Channel Staff - Friday, October 20, 6:48 AM. 86 Prior Close 70. Top 10 Holdings (14. The most heavily invested institutionals were Morgan Stanley ($614. In addition to holding 155 positions, its top 10 holdings make up just 14. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. Stock Analysis Chart Headlines Holdings Ownership Ratings. It's trading down (17%) versus LABU, down (68%) in one-year performance. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. ETFs - IBB, PBE, XBI. Some of the top XBI holdings continue to defy the bear market. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. 1. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc. The vast majority of XBI holdings have less than a 1% allocation in the fund. The latter proposal about IBB determines its main difference from XBI - the former is more focused on the large biotech companies (the share of Amgen Inc. 94 per share, with $116. 79 as the 52 week high point — that compares with a last trade of $126. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U. XBI ETF's holdings offer significant diversification. Meanwhile, XBI equal weights its holdings. SPDR S&P Biotech ETF is a equity fund issued by SSgA. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI. FBT has a higher 5-year return than XBI (-0. London. With XBI trading at a recent price near $122. Aug 4, 2021 10:47AM EDT. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. 94 per share, with $121. 4% of the stocks in our database. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. 60%. Its top 10 holdings account for approximately 16. S. BIIB is also in the top 15 XBI holdings. IBB's and XBI's Top Holdings are About to Break Out. 09% of its total assets under management. 87. View complete XBI exchange traded fund holdings for better informed ETF trading. The top 10 holdings account for about 10. Its fund flows were negative $259. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). 46% YTD Daily Total Return ETF Summary. ("Boron One" or the. SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. ETF. Lucy Brewster | Nov 10, 2023. The ETF has a beta of 1. SPDR S&P BIOTECH ETF. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. DLTR. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. 0. VHT has a higher 5-year return than XBI (7. 22% of total assets) As of November 16, 2023. , including minimum market capitalization and. Holdings AS OF 04/30/2023. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 06 as the 52 week high point — that compares with a last trade of $109. XBI's top 10 holdings account for about 11. 06 as the 52 week high point — that compares with a last trade of $102. $0. The. Please contact [email protected] XBI trading at a recent price near $81. S. 58 💸. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 80% of total assets under management. The XBI broke out in Q3 2016 and again in June 2017. 15 billion assets under management. Both BBH and XBI are ETFs. 80 per share, with $92. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. . Over a longer time than that, it has no top holdings. Chart. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. Per cent of portfolio in top 5 holdings: 8. Reply Like (7) q. 2. 0. , respectively. VHT has a lower expense ratio than XBI (0. Advertisement. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. 81 and $134. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). View complete YINN exchange traded fund holdings for better informed ETF trading. 2. While this ETF allocates. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 12% in the. S. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 64 billion, a PE ratio of 11. Snapshot: XBI. Looking at the chart above, XBI's low point in its 52 week range is $61. News & World Report, XBI. Top 10 Holdings. Check out the side-by-side comparison table of IBB vs. 01 per share, with $174. RGLD. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The top holdings of these ETFs are Exact Sciences Corp. 1. The following charts reflect the allocation of WCLD's underlying. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 2401 Millstream Rd 125 Victoria BC. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). Sector Exposure and Top Holdings. BTEK11. Assets Under Management. In addition to holding 155 positions, its top 10 holdings make up just 14. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Stock Analysis Chart Headlines Holdings Ownership Ratings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. It has a total of 153 holdings. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. by Morningstar Manager Research. A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. 06 a share on Wednesday which marked its lowest level dating back to June 30 of 2022. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. 60 as the 52 week high point — that compares with a last trade of $70. 5%, and a 2. The stock holdings of the XBI tends to be re.